Steatotic liver disease precisely assessed using 3D ultrafast vascular ultrasound

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...
MedPage Today

PET Imaging Falls Flat for Initial Liver Cancer Staging

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...
Morningstar

ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ENDRA Life Sciences Inc ...
The American Journal of Managed Care

Liver Fat Reduction Varied Across Pharmacologic Treatments for MASH

Reducing liver fat has become a central target in the development of therapies for metabolic dysfunction–associated ...
Study Finds on MSN

Everyday chemicals triple teen risk of liver disease

Age of exposure appears crucial: PFA contact among adolescents is linked to fatty liver disease, but not among young adults. In A Nutshell Forever chemicals linked to teen liver disease: Researchers ...